Glucocorticoid receptor control of transcription: Precision and plasticity via allostery

Nature Reviews Molecular Cell Biology

Volumn 18, Issue 3, 2017, Pages 159-174

  Weikum, Emily R ^a   Knuesel, Matthew T ^b   Ortlund, Eric A ^a   Yamamoto, Keith R ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MEDIATOR COMPLEX; METHYLTRANSFERASE; PROTEIN KINASE P160; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; DNA;

ALLOSTERISM; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA BINDING MOTIF; DNA RESPONSIVE ELEMENT; ENZYME BINDING; GENE INTERACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; NITROSYLATION; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR OCCUPANCY; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION; ACETYLATION; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN DOMAIN;

ACETYLATION; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; PROTEIN DOMAINS; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; SUMOYLATION; TRANSCRIPTION, GENETIC;

EID: 85008397832     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm.2016.152     Document Type: Review

References (168)

1. Bridgham, J. T. et al. Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor. PLoS Biol. 8, e1000497 (2010).
2. Revollo, J. R. & Cidlowski, J. A. Mechanisms generating diversity in glucocorticoid receptor signaling. Ann. NY Acad. Sci. 1179, 167-178 (2009).
3. Kadmiel, M. & Cidlowski, J. A. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol. Sci. 34, 518-530 (2013).
4. Lewis-Tuffin, L. J., Jewell, C. M., Bienstock, R. J., Collins, J. B. & Cidlowski, J. A. Human glucocorticoid receptor binds RU-486 and is transcriptionally active. Mol. Cell. Biol. 27, 2266-2282 (2007).
5. Picard, D. et al. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348, 166-168 (1990).
6. Chandler, V. L., Maler, B. A. & Yamamoto, K. R. DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 33, 489-499 (1983).
7. Yamamoto, K. R. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19, 209-252 (1985).
8. Yamamoto, K. R., Darimont, B. D., Wagner, R. L. & Iñiguez-Lluhí, J. A. Building transcriptional regulatory complexes: signals and surfaces. Cold Spring Harb. Symp. Quant. Biol. 63, 587-598 (1998).
9. McNally, J. G. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 287, 1262-1265 (2000).
10. Becker, M. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Rep. 3, 1188-1194 (2002).
11. Stavreva, D. A., Muller, W. G., Hager, G. L., Smith, C. L. & McNally, J. G. Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol. Cell. Biol. 24, 2682-2697 (2004).
12. Meijsing, S. H., Elbi, C., Luecke, H. F., Hager, G. L. & Yamamoto, K. R. The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release. Mol. Cell. Biol. 27, 2442-2451 (2007).
13. Sacta, M. A., Chinenov, Y. & Rogatsky, I. Glucocorticoid signaling: An update from a genomic perspective. Annu. Rev. Physiol. 78, 155-180 (2016).
14. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556 (1980).
15. Patel, R., Williams-Dautovich, J. & Cummins, C. L. Minireview: New molecular mediators of glucocorticoid receptor activity in metabolic tissues. Mol. Endocrinol. 28, 999-1011 (2014).
16. Kumar, R. & Thompson, E. B. The structure of the nuclear hormone receptors. Steroids 64, 310-319 (1999).
17. Luisi, B. F. et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505 (1991).
18. Meijsing, S. H. et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407-410 (2009).
19. Watson, L. C. et al. The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals. Nat. Struct. Mol. Biol. 20, 876-883 (2013).
20. Heck, S. et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13, 4087-4095 (1994).
21. Schiller, B. J., Chodankar, R., Watson, L. C., Stallcup, M. R. & Yamamoto, K. R. Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes. Genome Biol. 15, 418 (2014).
22. Reichardt, H. M. et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541 (1998).
23. Bledsoe, R. K. et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110, 93-105 (2002).
24. Surjit, M. et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241 (2011).
25. Hudson, W. H., Youn, C. & Ortlund, E. A. The structural basis of direct glucocorticoid-mediated transrepression. Nat. Struct. Mol. Biol. 20, 53-58 (2013).
26. Hudson, W. H. et al. Distal substitutions drive divergent DNA specificity among paralogous transcription factors through subdivision of conformational space. Proc. Natl Acad. Sci. USA 113, 326-331 (2016).
27. Lim, H. et al. Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo. Genome Res. 25, 836-844 (2015).
28. Miner, J. N. & Yamamoto, K. R. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev. 6, 2491-2501 (1992).
29. De Bosscher, K., Vanden Berghe, W. & Haegeman, G. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15, 219-227 (2001).
30. Luecke, H. F. & Yamamoto, K. R. The glucocorticoid receptor blocks P-TEFb recruitment by NFκB to effect promoter-specific transcriptional repression. Genes Dev. 19, 1116-1127 (2005).
31. De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: Molecular mechanisms for gene repression. Endocr. Rev. 24, 488-522 (2003).
32. Landt, S. G. et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 22, 1813-1831 (2012).
33. Steger, D. J. et al. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 24, 1035-1044 (2010).
34. John, S. et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264-268 (2011).
35. Grøntved, L. et al. C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J. 32, 1568-1583 (2013).
36. So, A. Y. L., Chaivorapol, C., Bolton, E. C., Li, H. & Yamamoto, K. R. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 3, e94 (2007).
37. Reddy, T. E. et al. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 19, 2163-2171 (2009).
38. Merkenschlager, M. & Nora, E. P. CTCF and cohesin in genome folding and transcriptional gene regulation. Annu. Rev. Genomics Hum. Genet. 17, 17-43 (2016).
39. Burd, C. J. et al. Analysis of chromatin dynamics during glucocorticoid receptor activation. Mol. Cell. Biol. 32, 1805-1817 (2012).
40. Telorac, J. et al. Identification and characterization of DNA sequences that prevent glucocorticoid receptor binding to nearby response elements. Nucleic Acids Res. 44, 6142-6156 (2016).
41. Uhlenhaut, N. H. et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell 49, 158-171 (2013).
42. Presman, D. M. et al. Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor. PLoS Biol. 12, e1001813 (2014).
43. Starick, S. R. et al. ChIP-exo signal associated with DNA-binding motifs provides insight into the genomic binding of the glucocorticoid receptor and cooperating transcription factors. Genome Res. 25, 825-835 (2015).
44. So, A. Y. L., Bernal, T. U., Pillsbury, M. L., Yamamoto, K. R. & Feldman, B. J. Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc. Natl Acad. Sci. USA 106, 17582-17587 (2009).
45. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308 (2013).
46. Rogatsky, I. et al. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 100, 13845-13850 (2003).
47. Thomas-Chollier, M. et al. A naturally occuring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms. Proc. Natl Acad. Sci. USA 110, 17826-17831 (2013).
48. Chen, S. H., Masuno, K., Cooper, S. B. & Yamamoto, K. R. Incoherent feed-forward regulatory logic underpinning glucocorticoid receptor action. Proc. Natl Acad. Sci. USA 110, 1964-1969 (2013).
49. Mangan, S. & Alon, U. Structure and function of the feed-forward loop network motif. Proc. Natl Acad. Sci. USA 100, 11980-11985 (2003).
50. Chinenov, Y., Coppo, M., Gupte, R., Sacta, M. A. & Rogatsky, I. Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages. BMC Genomics 15, 656 (2014).
51. Hudson, W. H. & Ortlund, E. A. The structure, function and evolution of proteins that bind DNA and RNA. Nat. Rev. Mol. Cell Biol. 15, 749-760 (2014).
52. Lefstin, J. A. & Yamamoto, K. R. Allosteric effects of DNA on transcriptional regulators. Nature 392, 885-888 (1998).
53. Presman, D. M. et al. DNA binding triggers tetramerization of the glucocorticoid receptor in live cells. Proc. Natl Acad. Sci. USA 113, 8236-8241 (2016).
54. Gebhardt, J. C. M. et al. Single-molecule imaging of transcription factor binding to DNA in live mammalian cells. Nat. Methods 10, 421-426 (2013).
55. Robblee, J. P., Miura, M. T. & Bain, D. L. Glucocorticoid receptor-promoter interactions: Energetic dissection suggests a framework for the specificity of steroid receptor-mediated gene regulation. Biochemistry 51, 4463-4472 (2012).
56. Bain, D. L. et al. Glucocorticoid receptor-DNA interactions: Binding energetics are the primary determinant of sequence-specific transcriptional activity. J. Mol. Biol. 422, 18-32 (2012).
57. Schöne, S. et al. Sequences flanking the core-binding site modulate glucocorticoid receptor structure and activity. Nat. Commun. 7, 12621 (2016).
58. Zhang, J. et al. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat. Struct. Mol. Biol. 18, 556-563 (2011).
59. Thornton, J. W. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc. Natl Acad. Sci. USA 98, 5671-5676 (2001).
60. Eick, G. N., Colucci, J. K., Harms, M. J., Ortlund, E. A. & Thornton, J. W. Evolution of minimal specificity and promiscuity in steroid hormone receptors. PLoS Genet. 8, e1003072 (2012).
61. He, Y. et al. Structures and mechanism for the design of highly potent glucocorticoids. Cell Res. 24, 713-726 (2014).
62. Kauppi, B. et al. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J. Biol. Chem. 278, 22748-22754 (2003).
63. Wang, J.-C. et al. Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev. 20, 689-699 (2006).
64. Ricketson, D., Hostick, U., Fang, L., Yamamoto, K. R. & Darimont, B. D. A conformational switch in the ligand-binding domain regulates the dependence of the glucocorticoid receptor on Hsp90. J. Mol. Biol. 368, 729-741 (2007).
65. Ismaili, N. & Garabedian, M. J. Modulation of glucocorticoid receptor function via phosphorylation. Ann. NY Acad. Sci. 1024, 86-101 (2004).
66. Tian, S., Poukka, H., Palvimo, J. J. & Jänne, O. A. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem. J. 367, 907-911 (2002).
67. Wallace, A. D. & Cidlowski, J. A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276, 42714-42721 (2001).
68. Itoh, M. et al. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol. Endocrinol. 16, 2382-2392 (2002).
69. Galigniana, M. D., Piwien-Pilipuk, G. & Assreuy, J. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol. Pharmacol. 55, 317-323 (1999).
70. Ward, R. D. & Weigel, N. L. Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation. BioFactors 35, 528-536 (2009).
71. Housley, P. R. & Pratt, W. B. Direct demonstration of glucocorticoid receptor phosphorylation by intact L-cells. J. Biol. Chem. 258, 4630-4635 (1983).
72. Wang, Z., Chen, W., Kono, E., Dang, T. & Garabedian, M. J. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. Mol. Endocrinol. 21, 625-634 (2007).
73. Bodwell, J. E. et al. Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65, 91-99 (1998).
74. Krstic, M. D., Rogatsky, I., Yamamoto, K. R. & Garabedian, M. J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947-3954 (1997).
75. Mason, S. A. & Housley, P. R. Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. J. Biol. Chem. 268, 21501-21504 (1993).
76. Jewell, C. M. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272, 9287-9293 (1997).
77. Chen, W. et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 22, 1754-1766 (2008).
78. Garza, A. M. S., Khan, S. H. & Kumar, R. Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor. Mol. Cell. Biol. 30, 220-230 (2010).
79. Miller, A. L. et al. p38 mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: Correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol. Endocrinol. 19, 1569-1583 (2005).
80. Wang, Z., Frederick, J. & Garabedian, M. J. Deciphering the phosphorylation 'code' of the glucocorticoid receptor in vivo. J. Biol. Chem. 277, 26573-26580 (2002).
81. King, K. L. & Cidlowski, J. A. Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60, 601-617 (1998).
82. Galliher-Beckley, A. J., Williams, J. G., Collins, J. B. & Cidlowski, J. A. Glycogen synthase kinase 3-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol. Cell. Biol. 28, 7309-7322 (2008).
83. Galliher-Beckley, A. J. & Cidlowski, J. A. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 61, 979-986 (2009).
84. Deroo, B. J. et al. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22, 4113-4123 (2002).
85. Wallace, A. D., Cao, Y., Chandramouleeswaran, S. & Cidlowski, J. A. Lysine 419 targets human glucocorticoid receptor for proteasomal degradation. Steroids 75, 1016-1023 (2010).
86. Kino, T., Liou, S. H., Charmandari, E. & Chrousos, G. P. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: Time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. Mol. Med. 10, 80-88 (2006).
87. Gill, G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15, 536-541 (2005).
88. Le Drean, Y., Mincheneau, N., Le Goff, P. & Michel, D. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143, 3482-3489 (2002).
89. Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V. & Palvimo, J. J. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res. 42, 1575-1592 (2014).
90. Treuter, E. & Venteclef, N. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochim. Biophys. Acta 1812, 909-918 (2011).
91. Flotho, A. & Melchior, F. Sumoylation: A regulatory protein modification in health and disease. Annu. Rev. Biochem. 82, 357-385 (2013).
92. Hua, G., Paulen, L. & Chambon, P. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression. Proc. Natl Acad. Sci. USA 113, E626-E634 (2016).
93. Hua, G., Ganti, K. P. & Chambon, P. Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex. Proc. Natl Acad. Sci. USA 113, E635-E643 (2016).
94. Nader, N., Chrousos, G. P. & Kino, T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 23, 1572-1583 (2009).
95. Kino, T. & Chrousos, G. P. Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: Circadian rhythm-associated alterations of glucocorticoid actions in target tissues. Mol. Cell. Endocrinol. 336, 23-30 (2011).
96. Ito, K. et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J. Exp. Med. 203, 7-13 (2006).
97. Kröncke, K. D. & Carlberg, C. Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide. FASEB J. 14, 166-173 (2000).
98. Diamond, M., Miner, J., Yoshinaga, S. & Yamamoto, K. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 249, 1266-1272 (1990).
99. Miner, J. N., Diamond, M. I. & Yamamoto, K. R. Joints in the regulatory lattice: Composite regulation by steroid receptor-AP1 complexes. Cell Growth Differ. 2, 525-530 (1991).
100. Jenkins, B. D., Pullen, C. B. & Darimont, B. D. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol. Metab. 12, 122-126 (2001).
101. Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381-395 (2011).
102. Millard, C. J., Watson, P. J., Fairall, L. & Schwabe, J. W. R. An evolving understanding of nuclear receptor coregulator proteins. J. Mol. Endocrinol. 51, T23-T36 (2013).
103. Vandevyver, S., Dejager, L. & Libert, C. Comprehensive overview of the structure and regulation of the glucocorticoid receptor. Endocr. Rev. 35, 671-693 (2014).
104. Parker, M. G. & White, R. Nuclear receptors spring into action. Nat. Struct. Biol. 3, 113-115 (1996).
105. Wang, Z. et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423, 555-560 (2003).
106. Torchia, J. et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684 (1997).
107. Heery, D. M., Kalkhoven, E., Hoare, S. & Parker, M. G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736 (1997).
108. Hu, X. & Lazar, M. A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402, 93-96 (1999).
109. Khan, S. H. et al. Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations. J. Biol. Chem. 287, 44546-44560 (2012).
110. Khan, S. H., Ling, J. & Kumar, R. TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1. PLoS ONE 6, e21939 (2011).
111. Dahlman-Wright, K., Almlöf, T., McEwan, I. J., Gustafsson, J. A. & Wright, A. P. Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression. Proc. Natl Acad. Sci. USA 91, 1619-1623 (1994).
112. Yang, L., Guerrero, J., Hong, H., DeFranco, D. B. & Stallcup, M. R. Interaction of the τ2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11, 2007-2018 (2000).
113. Chodankar, R., Wu, D. Y., Schiller, B. J., Yamamoto, K. R. & Stallcup, M. R. Hic-5 is a transcription coregulator that acts before and/or after glucocorticoid receptor genome occupancy in a gene-selective manner. Proc. Natl Acad. Sci. USA 111, 4007-4012 (2014).
114. Dasgupta, S., Lonard, D. M. & O'Malley, B. W. Nuclear receptor coactivators: Master regulators of human health and disease. Annu. Rev. Med. 65, 279-292 (2014).
115. Perissi, V. & Rosenfeld, M. G. Controlling nuclear receptors: The circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 6, 542-554 (2005).
116. Lonard, D. M. & O'Malley, B. W. Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Mol. Cell 27, 691-700 (2007).
117. Fonte, C. et al. Involvement of β-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells. Proc. Natl Acad. Sci. USA 102, 14260-14265 (2005).
118. Xu, J., Wu, R. C. & O'Malley, B. W. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 9, 615-630 (2009).
119. Kim, J. H., Li, H. & Stallcup, M. R. CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol. Cell 12, 1537-1549 (2003).
120. Stallcup, M. R. et al. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. J. Steroid Biochem. Mol. Biol. 85, 139-145 (2003).
121. Kim, J. H. et al. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell 31, 510-519 (2008).
122. Szapary, D., Huang, Y. & Simons, S. S. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol. Endocrinol. 13, 2108-2121 (1999).
123. Trousson, A. et al. Recruitment of the p160 coactivators by the glucocorticoid receptor: Dependence on the promoter context and cell type but not hypoxic conditions. J. Steroid Biochem. Mol. Biol. 104, 305-311 (2007).
124. Voegel, J. J. et al. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17, 507-519 (1998).
125. Darimont, B. D. et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356 (1998).
126. Li, X., Wong, J., Tsai, S. Y., Tsai, M. & O'Malley, B. W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 23, 3763-3773 (2003).
127. Kurihara, I. et al. Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol. Cell. Endocrinol. 189, 181-189 (2002).
128. Ronacher, K. et al. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol. Cell. Endocrinol. 299, 219-231 (2009).
129. Ogawa, H. et al. Nuclear structure-associated TIF2 recruits glucocorticoid receptor and its target DNA. Biochem. Biophys. Res. Commun. 320, 218-225 (2004).
130. Dobrovolna, J., Chinenov, Y., Kennedy, M. A., Liu, B. & Rogatsky, I. Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1. Mol. Cell. Biol. 32, 730-739 (2012).
131. Rogatsky, I., Luecke, H. F., Leitman, D. C. & Yamamoto, K. R. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl Acad. Sci. USA 99, 16701-16706 (2002).
132. Kamei, Y. et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414 (1996).
133. Sheppard, K.-A. et al. Nuclear integration of glucocorticoid receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273, 29291-29294 (1998).
134. De Bosscher, K. et al. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl Acad. Sci. USA 97, 3919-3924 (2000).
135. Allen, B. L. & Taatjes, D. J. The Mediator complex: A central integrator of transcription. Nat. Rev. Mol. Cell Biol. 16, 155-166 (2015).
136. Knuesel, M. T. & Taatjes, D. J. Mediator and post-recruitment regulation of RNA polymerase II. Transcription 2, 28-31 (2011).
137. Meyer, K. D., Lin, S. C., Bernecky, C., Gao, Y. & Taatjes, D. J. p53 activates transcription by directing structural shifts in Mediator. Nat. Struct. Mol. Biol. 17, 753-760 (2010).
138. Taatjes, D. J., Näär, A. M., Andel, F., Nogales, E. & Tjian, R. Structure, function, and activator-induced conformations of the CRSP coactivator. Science 295, 1058-1062 (2002).
139. Knuesel, M. T., Meyer, K. D., Bernecky, C. & Taatjes, D. J. The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev. 23, 439-451 (2009).
140. Bernecky, C., Grob, P., Ebmeier, C. C., Nogales, E. & Taatjes, D. J. Molecular architecture of the human Mediator-RNA polymerase II-TFIIF assembly. PLoS Biol. 9, e1000603 (2011).
141. Meyer, K. D. et al. Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3. EMBO J. 27, 1447-1457 (2008).
142. Hittelman, A. B., Burakov, D., Iñiguez-Lluhí, J. A., Freedman, L. P. & Garabedian, M. J. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 18, 5380-5388 (1999).
143. Chen, W., Rogatsky, I. & Garabedian, M. J. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol. Endocrinol. 20, 560-572 (2006).
144. Narlikar, G. J., Sundaramoorthy, R. & Owen-Hughes, T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell 154, 490-503 (2013).
145. Pazin, M. J. & Kadonaga, J. T. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell 88, 737-740 (1997).
146. Fryer, C. J. & Archer, T. K. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393, 88-91 (1998).
147. Engel, K. B. & Yamamoto, K. R. The glucocorticoid receptor and the coregulator Brm selectively modulate each other's occupancy and activity in a gene-specific manner. Mol. Cell. Biol. 31, 3267-3276 (2011).
148. Ostlund Farrants, A. K., Blomquist, P., Kwon, H. & Wrange, O. Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Mol. Cell. Biol. 17, 895-905 (1997).
149. Collingwood, T. N., Urnov, F. D. & Wolffe, A. P. Nuclear receptors: Coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endocrinol. 23, 255-275 (1999).
150. King, H. A., Trotter, K. W. & Archer, T. K. Chromatin remodeling during glucocorticoid receptor regulated transactivation. Biochim. Biophys. Acta 1819, 716-726 (2012).
151. Yoshinaga, S., Peterson, C., Herskowitz, I. & Yamamoto, K. R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258, 1598-1604 (1992).
152. Wallberg, A. E. et al. Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor τ1 activation domain. Mol. Cell. Biol. 20, 2004-2013 (2000).
153. Muratcioglu, S. et al. Structural modeling of GR interactions with the SWI/SNF chromatin remodeling complex and C/EBP. Biophys. J. 109, 1227-1239 (2015).
154. Chen, D. et al. Regulation of transcription by a protein methyltransferase. Science 284, 2174-2177 (1999).
155. Bittencourt, D. et al. G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes. Proc. Natl Acad. Sci. USA 109, 19673-19678 (2012).
156. Lee, K. K. & Workman, J. L. Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8, 284-295 (2007).
157. Almlöf, T., Wallberg, A. E., Gustafsson, J. Å. & Wright, A. P. H. Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor τ1-core activation domain and target factors. Biochemistry 37, 9586-9594 (1998).
158. Yao, T. P., Ku, G., Zhou, N., Scully, R. & Livingston, D. M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl Acad. Sci. USA 93, 10626-10631 (1996).
159. Wallberg, A. E. et al. Histone acetyltransferase complexes can mediate transcriptional activation by the major glucocorticoid receptor activation domain. Mol. Cell. Biol. 19, 5952-5959 (1999).
160. Fonte, C., Trousson, A., Grenier, J., Schumacher, M. & Massaad, C. Opposite effects of CBP and p300 in glucocorticoid signaling in astrocytes. J. Steroid Biochem. Mol. Biol. 104, 220-227 (2007).
161. Verdin, E. & Ott, M. 50 years of protein acetylation: From gene regulation to epigenetics, metabolism and beyond. Nat. Rev. Mol. Cell Biol. 16, 258-264 (2015).
162. Shahbazian, M. D. & Grunstein, M. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100 (2007).
163. Stewart, M. D. & Wong, J. Nuclear receptor repression: Regulatory mechanisms and physiological implications. Prog. Mol. Biol. Transl Sci. 87, 235-259 (2009).
164. Schoch, G. A. et al. Molecular switch in the glucocorticoid receptor: Active and passive antagonist conformations. J. Mol. Biol. 395, 568-577 (2010).
165. Kuznetsova, T. et al. Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization. Genome Biol. 16, 264 (2015).
166. Ogryzko, V. V. et al. Histone-like TAFs within the PCAF histone acetylase complex. Cell 94, 35-44 (1998).
167. Guenther, M. G., Barak, O. & Lazar, M. A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21, 6091-6101 (2001).
168. Chen, J. D. & Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457 (1995).